These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36977713)

  • 41. Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort.
    Vaes AW; Van Herck M; Deng Q; Delbressine JM; Jason LA; Spruit MA
    J Transl Med; 2023 Feb; 21(1):112. PubMed ID: 36765375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A logistic regression analysis of risk factors in ME/CFS pathogenesis.
    Lacerda EM; Geraghty K; Kingdon CC; Palla L; Nacul L
    BMC Neurol; 2019 Nov; 19(1):275. PubMed ID: 31699051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort.
    Close S; Marshall-Gradisnik S; Byrnes J; Smith P; Nghiem S; Staines D
    Front Public Health; 2020; 8():420. PubMed ID: 32974259
    [No Abstract]   [Full Text] [Related]  

  • 44. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
    Toogood PL; Clauw DJ; Phadke S; Hoffman D
    Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union.
    Strand EB; Nacul L; Mengshoel AM; Helland IB; Grabowski P; Krumina A; Alegre-Martin J; Efrim-Budisteanu M; Sekulic S; Pheby D; Sakkas GK; Sirbu CA; Authier FJ;
    PLoS One; 2019; 14(12):e0225995. PubMed ID: 31805176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
    Morris G; Maes M
    BMC Med; 2013 Sep; 11():205. PubMed ID: 24229326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myalgic Encephalomyelitis-Chronic Fatigue Syndrome Common Data Element item content analysis.
    Slavin MD; Bailey HM; Hickey EJ; Vasudevan A; Ledingham A; Tannenbaum L; Bateman L; Kaufman DL; Peterson DL; Ruhoy IS; Systrom DM; Felsenstein D; Kazis LE
    PLoS One; 2023; 18(9):e0291364. PubMed ID: 37698999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial.
    Anderson E; Parslow R; Hollingworth W; Mills N; Beasant L; Gaunt D; Metcalfe C; Kessler D; Macleod J; Pywell S; Pitts K; Price S; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
    J Med Internet Res; 2020 Aug; 22(8):e17768. PubMed ID: 32784188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cortical autonomic network connectivity predicts symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Zinn MA; Jason LA
    Int J Psychophysiol; 2021 Dec; 170():89-101. PubMed ID: 34662673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Smith MEB; Nelson HD; Haney E; Pappas M; Daeges M; Wasson N; McDonagh M
    Evid Rep Technol Assess (Full Rep); 2014 Dec; (219):1-433. PubMed ID: 30313001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.
    Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Mair JL; Ormerod J; Carless D; Hilliard N; Meach R; Ingram J; Sculthorpe NF
    J Transl Med; 2023 Oct; 21(1):720. PubMed ID: 37838675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001-2013: a Clinical Practice Research Datalink study.
    Collin SM; Bakken IJ; Nazareth I; Crawley E; White PD
    J R Soc Med; 2017 Jun; 110(6):231-244. PubMed ID: 28358988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severity Scales for Use in Primary Health Care to Assess Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Hardcastle SL; Brenu EW; Johnston S; Staines D; Marshall-Gradisnik S
    Health Care Women Int; 2016 Jun; 37(6):671-86. PubMed ID: 25315708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A critical analysis of the proposal of the Institute of Medicine to replace myalgic encephalomyelitis and chronic fatigue syndrome by a new diagnostic entity called systemic exertion intolerance disease.
    Twisk FN
    Curr Med Res Opin; 2015; 31(7):1333-47. PubMed ID: 25912615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Problems in defining post-exertional malaise.
    Jason LA; Evans M; So S; Scott J; Brown A
    J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.
    Bretherick AD; McGrath SJ; Devereux-Cooke A; Leary S; Northwood E; Redshaw A; Stacey P; Tripp C; Wilson J; Chowdhury S; Lewis I; Almelid Ø; Baby SV; Baker T; Becher H; Boutin T; Clyde M; Garcia D; Ireland J; Kerr SM; McDowall E; Perry D; Samms GL; Vitart V; Wolfe JC; Ponting CP
    NIHR Open Res; 2023; 3():20. PubMed ID: 37881452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
    Maksoud R; Magawa C; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    BMC Med; 2023 May; 21(1):189. PubMed ID: 37226227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subtyping Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) By Course of Illness.
    Stoothoff J; Gleason K; McManimen S; Thorpe T; Jason LA
    J Biosens Biomark Diagn; 2017; 2(1):. PubMed ID: 29204592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.